Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Does anyone else find it strange....
"The potential had been factored into the price many years ago....now we need execution and leadership. ..

What if the stock price could be boiled down to a function of the value of the assets multiplied by the capability of the Board of Directors to maximize its monetization. The latter is simply a 0-100% rating. If MMP could bring in $500M then apparently 25% comes off the top for the Leckrones leaving $375M split 50/50 so PTSC could net about $190M or about 45c per share.
If there's 20% confidence for maximum monetization via the current PTSC BoD (leadership) then that's 9c a share. Not far off and your mileage will vary.
Share
New Message
Please login to post a reply